Transplantation of T-cell-depleted C57BL/6-Nu/ Nu ("nude") bone marrow (BM) into C3H/HeJ recipients, conditioned with 8 Gy total body irradiation plus chemotherapy with the myeloablative drug dimethyl myleran, resulted in poor hematopoietic reconstitution 14 days posttransplant, compared with transplantation with T-cell-depleted BM from normal C57BL/6 donors. Hematopoietic reconstitution of "nude" BM could be improved by the addition of (C57BL/6xC3H/ HeJ)FI thymocytes void of graft-versus-host activity. Enhancement of BM allografting by thymocytes is sensitive to low -CELL DEPLETION of donor bone marrow (BM)
full donor-type chimerism (mice that survived the initial phase of aplasia were uniformly found to be durably engrafted with donor-type hematopoietic cells4), has enabled us to directly study the enhancing effect exerted by different thymocyte subpopulations on transplanted "nude" BM cells, without interference from hematopoietic recovery of residual host stem cells.
MATERIALS AND METHODS
Mice. Animals used were 8-to 12-week-old female C3H/HeJ and (C57BL16xC3H/HeJ)FI mice obtained from the Roscoe B. Jackson Memorial Laboratory (Bar Harbor, ME) and C57BL/6-Nu+/Nu+ mice obtained from Bomholtgard Breeding and Research Center Ltd (Bomholtgard, Denmark). All mice were kept in small cages (5 animals per cage) and fed sterile food and acid water.
Irradiation, DMM administration, and BM transplantation (BMT). Mice were exposed to a single dose of 8 GyTBI from a Gamma beam 150-A 6oCo source (produced by Atomic Energy of Canada, Canata, Ontario) at a focal skin distance of 75 cm, and at a 65 cGy/min dose rate. DMM (2,5-hexanediol dimethanesulfonate) was administered as previously described.' Briefly, DMM was injected intravenously (IV) (0.2 mg dissolved in a solution of 0.02 mL dimethylsulfoxide in 0.2 mL warm phosphate-buffered saline [PBS] ) 24 hours after 8 Gy TBI. TDBM cells were obtained by differential agglutination with soybean agglutinin according to Reisner et aI8 with minor modification^,^ and were transplanted into the irradiated mice 24 hours after the DMM treatment (IV in 0.2 mL PBS).
Thymocytes from (C57BLi 6xC3H/HeJ)FI mice were separated into PNA-and PNA+ fractions by differential agglutination with PNA, as described.I0
Twelve to 14 days after BMT, mice were bled from the retro-orbital vein using heparin-coated glass capillaries. Blood samples were counted for hemoglobin (Hb), platelets, and white blood cells (WBC) in a Coulter Counter S+11 (Coulter Electronics, Luton, UK).
After fractionation of thymocytes by PNA-, CD4+ and CD8+ cells in the PNA-cell fraction were stained by indirect immunofluorescence, using anti-L3T4 or Lyt-2 rat antibodies, respectively.'l.'* The second antibody was goat antirat Ig conjugated to fluorescein isothiocyanate (Yeda, Rehovot, Israel). Sorting was then performed in a fluorescence-activated cell sorter (FACS 440; Becton Dickinson, Sunnyvale, CA), with the laser set at 488 nm and 100 mW. Cells were sorted at a rate of not more than 2 x lo3 cellis. Inlet and collection tubes were cooled on ice. Sorted cells were then collected in 0.5 mL fetal calf serum in 4-mL glass tubes (Corning Glass Works, Corning, NY). The abort rate for coincident cells was reproducibly less than 10%.
RESULTS
Enhancement of "nude" BM engrafiment by (C57BL 1 6xC3H/Hd)Fl PNA-thymocytes in C3HIHd recipients. To investigate whether residual donor T cells present in TDBM affect the engraftment of such BM preparations, we tested the hematopoietic status of C3H/HeJ mice receiving TDBM from C57BLI6-NulNu mice, with or without PNAthymocytes from (C3H X C57BL16)Fl mice, after conditioning of the recipients with 8 Gy TBI plus DMM. This radiochemotherapy was shown to markedly eradicate residual host-type cells, and to afford donor-type chimerism after transplantation of a small dose of 1 to 2 x lo6 mismatched TDBM.4
As can be seen in Table 1 , the addition of F1 PNAthymocytes to nude BM markedly improved the hematopoietic reconstitution. In recipients of 1.5 x lo6 "nude" BM, platelet number and Hb levels on day 14 post-BMT were 65 ? 21 and 6.8 2 2.0, respectively, whereas in recipients of 1.5 x lo6 T-cell-depleted "nude" BM plus 7.5 x lo6 F1 PNA-thymocytes, these values were elevated to 378 f 255 and 11.4 ? 2.2, respectively (P < .Ol).
The effect of F1 PNA+ thymocytes on "nude" BM engrajb ment. The finding that T cells not alloreactive against the host, and therefore devoid of graft-versus-host activity, can enhance engraftment of T-cell-depleted "nude" BM suggests that this enhancement may be mediated by a T-cell subpopulation different from that which can initiate GVHD in alloreactive combinations. To address this, we initially examined whether BM enhancement could be mediated by immature PNA+ thymocytes, which in allogeneic models are devoid of graft-versus-host reactivity, as opposed to mature PNA-thymocytes, which are highly enriched for graft-versus-host activity.1° Table 2 shows that enhanced hematopoietic reconstitution 2 weeks posttransplant is achieved with the addition of mature PNA-thymocytes to "nude" BM cells, whereas immature PNA+ thymocytes do However, the addition of 6 x lo6 cells from the PNA-cell fraction (highly enriched with mature thymocytes) markedly elevated these values. Multiple comparison between the groups were performed by the Waller-Duncan method, using least significant difference (LSD). As can be seen in Table 2 , the effect of PNA-F1 thymocytes on all hematopoietic parameters were significant when tested at a confidence level of 95%, and the effect on platelets was significant at a confidence level of 99%. Because the PNA+ cell fraction is slightly contaminated with PNA-cells (2% to 5%), the difference between mice receiving PNA+ and PNA-cells is less significant than the difference between mice receiving PNA-cells and mice not receiving any T cells. Nevertheless, the difference in platelet level between mice receiving PNA+ thymocytes and mice receiving PNAthymocytes was significant at a confidence level of 99%. Radiation sensitivity of Fl PNA-thymocytes and its effect on "nude " donor-type hematopoietic reconstitution. Because T cells that mediate GVHD are radiation sensitive, it was of interest to investigate whether the enhancing effect achieved by adding F1 PNA-thymocytes to the BM inoculum is resistant to irradiation. In this way, we hoped to distinguish graft-versus-host activity from the enhancement of hematopoietic activity mediated by F1 PNA-thymocytes. However, our results showed that the F1 enhancing effect is extremely sensitive to irradiation already at a dose of 5 Gy. T-celldepleted "nude" BM cells (2.5 X lo6) were supplemented with 4 x lo6 F1 PNA-thymocytes irradiated at different doses in vitro, and were transplanted into C3H/HeJ recipients previously conditioned with 8 Gy TBI + 0.2 mg DMM.
As can be seen in Table 3 , the enhancing activity of the F1 PNA-thymocytes is lost after administering radiation doses of 2 5.0 Gy. The platelet values and Hb levels in mice receiving 4 x lo6 nonirradiated F1 PNA-thymocytes (242 f 89 and 10.4 ? 1.0, respectively) were significantly higher than in all other groups, whereas values in mice who received F1 PNA-thymocytes irradiated with 5 Gy were 56 f 27 and 6.5 ? 1.9, respectively, similar to values in the control group (56.0 ? 20 and 7.8 ? 1.4, respectively) who received a transplant of "nude" BM cells without F1 PNAthymocytes.
Effect of timing on administration of Fl PNA-thymocytes. To investigate whether the T-cell-enhancing effect is dependent on coincubation or coadministration of "nude" BM cells with F1 PNA-thymocytes, these cells were infused 24 and 72 hours after transplantation of T-cell-depleted "nude" BM cells. As can be seen in Table 4 , infusion of F1 PNAthymocytes 24 hours, but not 72 hours, after BMT could significantly enhance hematopoietic reconstitution, although the coadministration of BM cells and T cells was most effective. Enhancement of platelet number by administration of F1 thymocytes on day 0 was significantly higher compared with administration on day +l. All the hemato- poietic values found when T cells were infused 72 hours post-BMT, were not significantly different from those found in control mice not receiving F1 thymocytes (Table   CD8+ CD4-PNA-Fl thymocytes mediate the enhancement of BM allografis. It has been shown that the PNAcell fraction is highly enriched for the "single positive" L3T4+Lyt2-and the Lyt2+L3T4-thymocytes, which are more immunocompetent in various immunologic activities in vivo and in vitro1° than the "double positive" L3T4+Lyt2+ thymocytes comprising the PNA+ cell fraction. Thus, the unagglutinated PNA-fraction was further fractionated into CD4+ and CD8+ subpopulations. About 20% to 30% of the PNA-thymocyte cell fraction are Lyt2+ (CD8+), while 70% to 80% of the cells are L3T4+ (CD4+). By using cell sorting, highly enriched cell fractions ( > 95% pure) of 4).
CD8+ and CD8-cells could be obtained (Fig 1) and then mixed with T-cell-depleted "nude" BM before transplantation into lethally irradiated C3H/HeJ recipients. As can be seen in Table 5 , the CD8+ PNA-cell fraction was found to be superior in promoting hematopoietic engraftment compared with the CD8-cells, which did not enhance donortype hematopoiesis when added to T-cell-depleted "nude" BM. In both experiments, all the hematopoietic parameters were significantly elevated by the addition of CD8+ cells in the PNA-F1 thymocyte fraction compared with the values found in the mice receiving BM together with the CD8-cells. The CD8+ cell fraction was found to have a significantly greater effect statistically when compared with unsorted F1 thymocytes, suggesting that a marked enrichment for the enhancing activity was obtained in the purified CD8+ cell subpopulation. PNA-F1 thymocytes were administered at different time intervals after the transplantation of TDBM cells from C57BLIG-NuINu mice. The values expressed are the mean t SD for each group. *The statistical significance was determined by multiple comparisons between the three groups in each experiment according to the Waller-Duncan method, using the LSD: +, 95% significance; ++, 99% significance; -, not significant. Only comparisons that show a significant difference are given.
DISCUSSION
In current clinical trials involving allogeneic TDBM, attempts are being made to selectively add small numbers of donor-type T cells to the BM inoculum so as to avoid
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Fluorescence (CD8) GVHD but still improve engraftment. At present, however, these attempts have met with only limited success because of difficulties in controlling GVHD after the addition of donor-type 1ymph0cytes.l~
In a previous study, we showed that F1 PNA-thymocytes devoid of GVHD can enhance engraftment of allogeneic TDBM.6 This observation was in accordance with that of Navarro and Touraine, who showed that F1 spleen T cells can enhance engraftment of F1 fetal liver cells in the lethally irradiated parental strain.l4 It has become increasingly clear that, in the absence of alloreactivity against host-type cells, a T-cell subpopulation may be capable of enhancing engraftment of BM allografts. The characterization and purification of such cells is critical to an understanding of the interaction between donor BM stem cells and the host microenvironment. Moreover, such knowledge is also of clinical significance, as it could help to determine which T-cell subpopulations should be spared when T-cell purging is used to avoid GVHD.
Champlin et all5 have attempted recently to eliminate
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CD8+ T cells from HLA-identical transplants. The growing experience with this approach in chronic myeloid leukemia (CML) patients suggests that, unlike results found in rccipients of TDBM, the graft versus leukemia effect was retained. However, graft rejection or failure was similar to that found in recipients of pan-TDBM. Although tempered, GVHD remains a problem and it is impossible to distinguish in these patients between GVHD and graft versus leukemia. Several murine studies have shown that both tl:e CD4+ and the CD8+ T-cell subpopulations are capable of inducing GVHD in mice.16 Our present finding that CD8+ and not CD4+ T cells mediate the enhancement of BM allografting suggests that sparing of the former cells may be more beneficial for allogeneic BMT in humans. The apparent enhancement of engraftment by T cells in a model designed to avoid GVHD suggests that it is independent of alloreactivity. However, alloreactive T cells may be inseparable from the subpopulation involved in BM allograft enhancement, as was exemplified by our finding that enhancement of engraftment cannot be achieved by immature T cells nor by irradiated T cells, both of which are incapable of mounting a graft-versus-host response in allogeneic recipients. PNA-CD8+ CD4-thymocytes, shown to be solely responsible for the enhancement of the BM allografting subpopulation, comprise less than 3% of the total thymocyte population; nevertheless, they are known to be capable of inducing GVHD in mice.I6 Further fractionation and classification of this highly purified thymocyte subpopulation may clarify whether GVHD-producing T cells can be distinguished from those T cells that enhance hematopoietic reconstitution.
The role established in the present study for CD8+ cells in the enhancement of BM reconstitution may also be relevant to the mechanism by which T cells contribute to hematopoiesis. CD8+ T cells are known to be restricted to class I H-2 antigens; it is therefore possible that the enhancement of "nude" BM allografts may be mediated by the interaction of CD8+ T cells from the haploidentical F1 donor with class I molecules on the host stroma cell and/or the donor stem cell. In H-2-identical recipients, a sufficient number of residual host T cells may remain after TBI, so that T-cell depletion of the transplanted marrow may not ultimately lead to graft failure. On the other hand, donortype stem cells in TDBM allografts may not be able to interact effectively with the residual host cells when donor and host are mismatched at class I H-2. As a consequence, CD8+ T cells sharing donor class I determinants may have to be added to the BM inoculum. This hypothesis is presently being investigated by transplanting TDBM into class I cogenic and transgenic recipients.
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